BamSEC and AlphaSense Join Forces
Learn More

Biocancell Therapeutics Inc.

Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.5
from 10-K 7 pages Biocancell Therapeutics Inc. Warrant to Purchase Shares of Common Stock (Subject to Adjustment) of Biocancell Therapeutics Inc. (The “Company”) at a Per Share Price and Subject to the Terms Detailed Below Void After 17:00 P.M. Eastern Standard Time on the Last Day of the Warrant Period
12/34/56
EX-4.5
from S-1/A 1 page - Convenience Translation From Hebrew - Biocancell Therapeutics Inc
12/34/56
EX-4.6
from S-1/A 8 pages Biocancell Therapeutics Inc. Assignable Warrant to Purchase Shares of Common Stock of Biocancell Therapeutics, Inc. (The “Company”) at a Per Share Price and Subject to the Terms Detailed Below Void After 5:00 P.M. New York Time on the Last Day of the Warrant Period
12/34/56
EX-4.5
from S-1/A 8 pages Biocancell Therapeutics Inc. Assignable Warrant to Purchase Shares of Common Stock of Biocancell Therapeutics, Inc. (The “Company”) at a Per Share Price and Subject to the Terms Detailed Below Void After 5:00 P.M. New York Time on the Last Day of the Warrant Period
12/34/56
EX-4.4
from S-1 11 pages Biocancell Therapeutics Inc. Assignable Warrant to Purchase Shares of Common Stock (Subject to Adjustment) of Biocancell Therapeutics Inc. (The “Company”) at a Per Share Price and Subject to the Terms Detailed Below Void After 17:00 P.M. Eastern Standard Time on the Last Day of the Warrant Period
12/34/56
EX-4.3
from S-1 11 pages Unsecured Convertible Promissory Note
12/34/56
EX-4.2
from S-1 1 page Re: Allocation Letter for Series 2 Warrants of Biocancell Therapeutics, Inc, a Delaware Corporation
12/34/56
EX-4.1
from S-1 ~1 page Secretary/Treasurer
12/34/56